Pax Neuroscience is a life sciences company focused on the development and commercialization of protein biomarker-based clinical laboratory services and products that address unmet needs in the fields of neuroscience and psychiatry. It focuses on the development of biomarker assays to inform patient and clinician decisions and to offer services to pharma companies. The company develops blood tests for depression diagnosis and for an antidepressant response.